Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18

We sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18) using cell-free DNA obtained from maternal blood. We assayed cell-free DNA from a training set and a blinded validation set of pregnant women, comprising 2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of obstetrics and gynecology Jg. 206; H. 4; S. 319.e1 - 319.e9
Hauptverfasser:	Sparks, Andrew B., Struble, Craig A., Wang, Eric T., Song, Ken, Oliphant, Arnold
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York, NY Mosby, Inc 01.04.2012 Elsevier
Schlagworte:	Adult aneuploidy detection Biological and medical sciences Case-Control Studies Chromosome aberrations Chromosomes, Human, Pair 18 - genetics DNA - blood DNA - genetics Down syndrome Down Syndrome - diagnosis Female Fetus Gynecology. Andrology. Obstetrics Humans Male Medical genetics Medical sciences noninvasive prenatal diagnostics Obstetrics and Gynecology Pregnancy Pregnancy Trimester, First - blood Prenatal Diagnosis - methods Risk Sensitivity and Specificity trisomy Trisomy - diagnosis aneuploidy detection noninvasive prenatal diagnostics Down syndrome trisomy Chromosomal aberration Trisomy Gynecology Aneuploidy Obstetrics Blood Chromosome E18 Prenatal diagnosis Mother DNA Cell Edwards syndrome
ISSN:	0002-9378, 1097-6868, 1097-6868
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	We sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18) using cell-free DNA obtained from maternal blood. We assayed cell-free DNA from a training set and a blinded validation set of pregnant women, comprising 250 disomy, 72 T21, and 16 T18 pregnancies. We used digital analysis of selected regions in combination with a novel algorithm, fetal-fraction optimized risk of trisomy evaluation (FORTE), to determine trisomy risk for each subject. In all, 163/171 subjects in the training set passed quality control criteria. Using a Z statistic, 35/35 T21 cases and 7/7 T18 cases had Z statistic >3 and 120/121 disomic cases had Z statistic <3. FORTE produced an individualized trisomy risk score for each subject, and correctly discriminated all T21 and T18 cases from disomic cases. All 167 subjects in the blinded validation set passed quality control and FORTE performance matched that observed in the training set correctly discriminating 36/36 T21 cases and 8/8 T18 cases from 123/123 disomic cases. Digital analysis of selected regions and FORTE enable accurate, scalable noninvasive fetal aneuploidy detection.
AbstractList	We sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18) using cell-free DNA obtained from maternal blood. We assayed cell-free DNA from a training set and a blinded validation set of pregnant women, comprising 250 disomy, 72 T21, and 16 T18 pregnancies. We used digital analysis of selected regions in combination with a novel algorithm, fetal-fraction optimized risk of trisomy evaluation (FORTE), to determine trisomy risk for each subject. In all, 163/171 subjects in the training set passed quality control criteria. Using a Z statistic, 35/35 T21 cases and 7/7 T18 cases had Z statistic >3 and 120/121 disomic cases had Z statistic <3. FORTE produced an individualized trisomy risk score for each subject, and correctly discriminated all T21 and T18 cases from disomic cases. All 167 subjects in the blinded validation set passed quality control and FORTE performance matched that observed in the training set correctly discriminating 36/36 T21 cases and 8/8 T18 cases from 123/123 disomic cases. Digital analysis of selected regions and FORTE enable accurate, scalable noninvasive fetal aneuploidy detection. We sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18) using cell-free DNA obtained from maternal blood.OBJECTIVEWe sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18) using cell-free DNA obtained from maternal blood.We assayed cell-free DNA from a training set and a blinded validation set of pregnant women, comprising 250 disomy, 72 T21, and 16 T18 pregnancies. We used digital analysis of selected regions in combination with a novel algorithm, fetal-fraction optimized risk of trisomy evaluation (FORTE), to determine trisomy risk for each subject.STUDY DESIGNWe assayed cell-free DNA from a training set and a blinded validation set of pregnant women, comprising 250 disomy, 72 T21, and 16 T18 pregnancies. We used digital analysis of selected regions in combination with a novel algorithm, fetal-fraction optimized risk of trisomy evaluation (FORTE), to determine trisomy risk for each subject.In all, 163/171 subjects in the training set passed quality control criteria. Using a Z statistic, 35/35 T21 cases and 7/7 T18 cases had Z statistic >3 and 120/121 disomic cases had Z statistic <3. FORTE produced an individualized trisomy risk score for each subject, and correctly discriminated all T21 and T18 cases from disomic cases. All 167 subjects in the blinded validation set passed quality control and FORTE performance matched that observed in the training set correctly discriminating 36/36 T21 cases and 8/8 T18 cases from 123/123 disomic cases.RESULTSIn all, 163/171 subjects in the training set passed quality control criteria. Using a Z statistic, 35/35 T21 cases and 7/7 T18 cases had Z statistic >3 and 120/121 disomic cases had Z statistic <3. FORTE produced an individualized trisomy risk score for each subject, and correctly discriminated all T21 and T18 cases from disomic cases. All 167 subjects in the blinded validation set passed quality control and FORTE performance matched that observed in the training set correctly discriminating 36/36 T21 cases and 8/8 T18 cases from 123/123 disomic cases.Digital analysis of selected regions and FORTE enable accurate, scalable noninvasive fetal aneuploidy detection.CONCLUSIONDigital analysis of selected regions and FORTE enable accurate, scalable noninvasive fetal aneuploidy detection. Objective We sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18) using cell-free DNA obtained from maternal blood. Study Design We assayed cell-free DNA from a training set and a blinded validation set of pregnant women, comprising 250 disomy, 72 T21, and 16 T18 pregnancies. We used digital analysis of selected regions in combination with a novel algorithm, fetal-fraction optimized risk of trisomy evaluation (FORTE), to determine trisomy risk for each subject. Results In all, 163/171 subjects in the training set passed quality control criteria. Using a Z statistic, 35/35 T21 cases and 7/7 T18 cases had Z statistic >3 and 120/121 disomic cases had Z statistic <3. FORTE produced an individualized trisomy risk score for each subject, and correctly discriminated all T21 and T18 cases from disomic cases. All 167 subjects in the blinded validation set passed quality control and FORTE performance matched that observed in the training set correctly discriminating 36/36 T21 cases and 8/8 T18 cases from 123/123 disomic cases. Conclusion Digital analysis of selected regions and FORTE enable accurate, scalable noninvasive fetal aneuploidy detection.
Author	Wang, Eric T. Sparks, Andrew B. Struble, Craig A. Oliphant, Arnold Song, Ken
Author_xml	– sequence: 1 givenname: Andrew B. surname: Sparks fullname: Sparks, Andrew B. – sequence: 2 givenname: Craig A. surname: Struble fullname: Struble, Craig A. – sequence: 3 givenname: Eric T. surname: Wang fullname: Wang, Eric T. – sequence: 4 givenname: Ken surname: Song fullname: Song, Ken email: ksong@ariadx.com – sequence: 5 givenname: Arnold surname: Oliphant fullname: Oliphant, Arnold
BackLink	http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25784870$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22464072$$D View this record in MEDLINE/PubMed
BookMark	eNqFkl2L1DAUhousuLOrf8ALyY141ZqTdtJ0EWFZP2FZL9TrkKYnkjFNxqQzMD_C_2w6HwgLrhBIDnneN5zz5qI488FjUTwHWgEF_npVqVX4UTEKrKJQ0Zo-KhZAu7bkgouzYkEpZWVXt-K8uEhpNZesY0-Kc8Ya3tCWLYrfd8Fbv1XJbpGsI3o1KUcGnFBPNnii_EASurnKgPLK7ZJNJBii0bnSRETy7u6ahH5S1uNATAwjGdWEMbOkdyEMVwS3ym3U3tCESKZoUxh3hMHe_1SCeFo8NsolfHbcL4vvH95_u_lU3n75-Pnm-rbUTQdT2YM2HHTd90IzpQEbaHuEbmgG3jLV9Xk1db4U1NC-W9bdUjAtBAeDhvO-vixeHXzXMfzaYJrkaNPckPIYNkl2vBY17wAy-eJIbvoRB7mOdlRxJ08TzMDLI6CSVs5E5bVNf7llKxrR0syJA6djSCmikdpO-5FMUVkngco5VLmSc6hyDlVSkDnULGX3pCf3B0VvDiLMc9xajDJpi17jYGNOUw7BPix_e0-unfU2d_gTd5hWYTPnmyTIlDXy6_y35p8GLJ84zAZX_zb43-t_AIxc5DM
CODEN	AJOGAH
CitedBy_id	crossref_primary_10_1186_s12920_020_00751_8 crossref_primary_10_1016_j_ajog_2015_03_043 crossref_primary_10_1038_srep38359 crossref_primary_10_1159_000484317 crossref_primary_10_1002_pd_4511 crossref_primary_10_1371_journal_pone_0093559 crossref_primary_10_1016_j_bpobgyn_2012_03_004 crossref_primary_10_1146_annurev_genom_090413_025341 crossref_primary_10_1002_uog_12331 crossref_primary_10_1002_pd_4639 crossref_primary_10_1186_s12920_016_0182_9 crossref_primary_10_1002_pd_5603 crossref_primary_10_1073_pnas_1406103111 crossref_primary_10_1080_14767058_2019_1686478 crossref_primary_10_1016_j_tjog_2013_10_003 crossref_primary_10_1093_clinchem_hvac207 crossref_primary_10_1002_pd_4195 crossref_primary_10_1186_s12913_023_09245_6 crossref_primary_10_1002_pd_4194 crossref_primary_10_1002_pd_4076 crossref_primary_10_1016_j_fertnstert_2013_02_012 crossref_primary_10_1016_j_jgyn_2015_08_003 crossref_primary_10_1016_j_ajog_2012_01_029 crossref_primary_10_1002_pd_6126 crossref_primary_10_1373_clinchem_2013_207951 crossref_primary_10_1002_pd_5036 crossref_primary_10_1016_j_ajog_2012_08_033 crossref_primary_10_1159_000441945 crossref_primary_10_1001_jamanetworkopen_2019_1062 crossref_primary_10_1136_bmjopen_2015_010002 crossref_primary_10_1002_pd_4625 crossref_primary_10_1371_journal_pone_0186771 crossref_primary_10_3390_diagnostics3020291 crossref_primary_10_1016_j_ajog_2012_05_021 crossref_primary_10_1002_pd_4182 crossref_primary_10_1002_uog_15749 crossref_primary_10_1016_j_molmed_2016_09_008 crossref_primary_10_1159_000356495 crossref_primary_10_3109_01443615_2014_930100 crossref_primary_10_1007_s00216_018_1092_9 crossref_primary_10_1080_14737159_2021_1911651 crossref_primary_10_1016_j_ajog_2014_08_006 crossref_primary_10_1002_pd_4615 crossref_primary_10_7326_M14_0698 crossref_primary_10_1111_1471_0528_14050 crossref_primary_10_1002_uog_15851 crossref_primary_10_1097_AOG_0000000000000363 crossref_primary_10_1002_uog_15733 crossref_primary_10_1002_uog_15975 crossref_primary_10_1002_pd_3993 crossref_primary_10_1002_pd_4841 crossref_primary_10_1016_j_jmoldx_2015_10_003 crossref_primary_10_1186_s13039_019_0459_8 crossref_primary_10_2337_diaspect_29_2_105 crossref_primary_10_1373_clinchem_2012_196212 crossref_primary_10_1007_s12611_016_0358_8 crossref_primary_10_1177_8756479313517766 crossref_primary_10_1515_cclm_2012_0281 crossref_primary_10_1002_pd_5814 crossref_primary_10_1111_ajo_12136 crossref_primary_10_1002_uog_14791 crossref_primary_10_1002_uog_17386 crossref_primary_10_1002_uog_14792 crossref_primary_10_1002_mgg3_1232 crossref_primary_10_1097_AOG_0000000000004833 crossref_primary_10_1002_pd_4160 crossref_primary_10_1002_pd_4159 crossref_primary_10_1038_nbt_2627 crossref_primary_10_57264_cer_2022_0168 crossref_primary_10_1080_14767058_2019_1702963 crossref_primary_10_1002_pd_4157 crossref_primary_10_1155_2014_823504 crossref_primary_10_1016_j_bpobgyn_2017_02_007 crossref_primary_10_1002_pd_4712 crossref_primary_10_1016_j_ajog_2012_02_021 crossref_primary_10_1002_uog_14664 crossref_primary_10_1002_uog_14666 crossref_primary_10_1002_ajmg_c_31356 crossref_primary_10_1002_uog_18905 crossref_primary_10_3389_fgene_2022_999587 crossref_primary_10_1002_pd_4270 crossref_primary_10_1002_pd_6448 crossref_primary_10_1002_pd_6328 crossref_primary_10_1159_000358326 crossref_primary_10_1371_journal_pone_0057381 crossref_primary_10_1159_000367626 crossref_primary_10_1002_uog_14690 crossref_primary_10_1002_uog_14692 crossref_primary_10_1002_pd_5908 crossref_primary_10_1002_uog_14694 crossref_primary_10_1002_uog_15783 crossref_primary_10_1111_ajo_12117 crossref_primary_10_3233_NPM_161618 crossref_primary_10_1007_s10897_012_9564_0 crossref_primary_10_1016_j_siny_2013_10_003 crossref_primary_10_1097_AOG_0000000000000452 crossref_primary_10_3109_14767058_2014_947579 crossref_primary_10_1016_j_placenta_2022_03_126 crossref_primary_10_1002_pd_4139 crossref_primary_10_1097_GCO_0b013e32835f3eec crossref_primary_10_3390_genes15121590 crossref_primary_10_1016_j_ajogmf_2022_100846 crossref_primary_10_1159_000362940 crossref_primary_10_1016_j_ajog_2016_04_029 crossref_primary_10_1016_j_jbiotec_2019_04_020 crossref_primary_10_1111_ajo_12223 crossref_primary_10_1177_0969141313476496 crossref_primary_10_1002_uog_14683 crossref_primary_10_1097_OGX_0000000000001297 crossref_primary_10_1016_j_ajog_2014_09_012 crossref_primary_10_1002_pd_5583 crossref_primary_10_3390_jcm11164760 crossref_primary_10_1016_j_ajog_2013_03_027 crossref_primary_10_1586_14737159_2015_1051529 crossref_primary_10_1186_s12967_018_1705_2 crossref_primary_10_1002_pd_4126 crossref_primary_10_3109_14767058_2012_722731 crossref_primary_10_1002_pd_4804 crossref_primary_10_3389_fgene_2022_1047474 crossref_primary_10_1057_s41292_019_00171_7 crossref_primary_10_1097_AOG_0000000000001406 crossref_primary_10_1097_MOH_0b013e328358e17a crossref_primary_10_1016_j_ogc_2017_10_001 crossref_primary_10_1080_14767058_2021_1879043 crossref_primary_10_1080_10408363_2022_2162843 crossref_primary_10_1586_14737159_2015_973857 crossref_primary_10_1016_j_gofs_2017_12_011 crossref_primary_10_1002_ijgo_13976 crossref_primary_10_1002_pd_4599 crossref_primary_10_1002_pd_4111 crossref_primary_10_1101_gr_278413_123 crossref_primary_10_1002_uog_12299 crossref_primary_10_1002_pd_4914 crossref_primary_10_1371_journal_pone_0159648 crossref_primary_10_1080_10408363_2019_1631749 crossref_primary_10_1159_000356075 crossref_primary_10_1002_pd_4119 crossref_primary_10_1373_clinchem_2018_299602 crossref_primary_10_1002_pd_5328 crossref_primary_10_1515_dx_2015_0002 crossref_primary_10_1007_s10897_016_9976_3 crossref_primary_10_1016_j_bpobgyn_2014_01_002 crossref_primary_10_1016_j_molmed_2014_12_006 crossref_primary_10_1373_clinchem_2016_260034 crossref_primary_10_1098_rsob_120086 crossref_primary_10_1016_j_ajog_2014_11_041 crossref_primary_10_1159_000355653 crossref_primary_10_1002_pd_4103 crossref_primary_10_1159_000355655 crossref_primary_10_1002_pd_4468 crossref_primary_10_1002_pd_4589 crossref_primary_10_3390_jcm3020388 crossref_primary_10_1159_000356066 crossref_primary_10_1373_clinchem_2013_202663 crossref_primary_10_1002_pd_4101 crossref_primary_10_1002_uog_13377 crossref_primary_10_1016_j_ajog_2015_12_018 crossref_primary_10_1371_journal_pgen_1011484 crossref_primary_10_1002_pd_4229 crossref_primary_10_1002_pd_6408 crossref_primary_10_1002_pd_4109 crossref_primary_10_1016_j_clp_2014_08_013 crossref_primary_10_1002_mgg3_1256 crossref_primary_10_1016_j_ajog_2014_10_012 crossref_primary_10_1093_humrep_dey033 crossref_primary_10_1111_ajo_12432 crossref_primary_10_1177_0969141315581005 crossref_primary_10_1016_j_tjog_2021_05_028 crossref_primary_10_1016_j_ajog_2015_12_025 crossref_primary_10_1080_14767058_2019_1594190 crossref_primary_10_1016_j_cca_2013_10_007 crossref_primary_10_1016_j_placenta_2022_02_003 crossref_primary_10_3390_diagnostics13152532 crossref_primary_10_1002_uog_12513 crossref_primary_10_1016_j_labinv_2022_100043 crossref_primary_10_3390_diagnostics2040057 crossref_primary_10_1016_j_rbmo_2013_08_008 crossref_primary_10_1097_QAI_0000000000001650 crossref_primary_10_1155_2013_208482 crossref_primary_10_1002_pd_4338 crossref_primary_10_1155_2016_2714341 crossref_primary_10_1007_s00404_018_4983_2 crossref_primary_10_1159_000510069 crossref_primary_10_1111_aogs_13047 crossref_primary_10_1002_uog_18968 crossref_primary_10_1373_clinchem_2013_203299 crossref_primary_10_1002_pd_4686 crossref_primary_10_1371_journal_pone_0167130 crossref_primary_10_1109_ACCESS_2020_3000483 crossref_primary_10_1002_pd_4561 crossref_primary_10_1371_journal_pone_0088484 crossref_primary_10_1017_S0965539516000061 crossref_primary_10_1586_erm_12_24 crossref_primary_10_1111_jep_12557 crossref_primary_10_1016_j_cll_2016_01_002 crossref_primary_10_1002_uog_18993 crossref_primary_10_1056_NEJMoa1407349 crossref_primary_10_1080_14767058_2016_1253062 crossref_primary_10_3892_br_2016_653 crossref_primary_10_1097_AOG_0000000000000874 crossref_primary_10_1371_journal_pone_0215368 crossref_primary_10_1002_uog_29098 crossref_primary_10_1515_cclm_2012_0601 crossref_primary_10_1007_s40142_013_0010_x crossref_primary_10_17795_compreped_23254 crossref_primary_10_1097_AOG_0b013e31827e5c85 crossref_primary_10_1016_j_jogoh_2019_07_001 crossref_primary_10_1002_uog_19036 crossref_primary_10_1146_annurev_med_091014_115715 crossref_primary_10_1159_000512501 crossref_primary_10_1016_j_cll_2016_01_010 crossref_primary_10_1016_j_cll_2016_01_015 crossref_primary_10_1016_S1701_2163_15_31025_2 crossref_primary_10_2217_bmm_14_18 crossref_primary_10_1371_journal_pone_0161928 crossref_primary_10_3389_fped_2022_812781 crossref_primary_10_1002_uog_15913 crossref_primary_10_1055_s_0042_1743573 crossref_primary_10_1002_pd_4301 crossref_primary_10_1016_j_cca_2014_12_026 crossref_primary_10_1002_pd_4541 crossref_primary_10_1093_humupd_dmt001 crossref_primary_10_1159_000357198 crossref_primary_10_1097_GRF_0000000000000172 crossref_primary_10_1002_pd_4306 crossref_primary_10_1002_uog_23648 crossref_primary_10_1111_1471_0528_14197 crossref_primary_10_1002_uog_17562 crossref_primary_10_1371_journal_pone_0110240 crossref_primary_10_3390_genes11060590 crossref_primary_10_1002_pd_4780 crossref_primary_10_1371_journal_pone_0199010 crossref_primary_10_1002_uog_20290 crossref_primary_10_1016_j_ejogrb_2021_02_013 crossref_primary_10_1002_pd_5621 crossref_primary_10_1002_pd_4777 crossref_primary_10_1002_uog_12436 crossref_primary_10_1111_cge_12598 crossref_primary_10_1002_pd_5620 crossref_primary_10_1186_s12884_018_1930_y crossref_primary_10_1016_j_ymgme_2018_10_002 crossref_primary_10_1002_pd_4779 crossref_primary_10_1002_pd_6836 crossref_primary_10_3389_fgene_2021_630787 crossref_primary_10_1016_j_gyobfe_2012_12_015 crossref_primary_10_1016_j_tjog_2019_05_021 crossref_primary_10_4000_cdst_6542 crossref_primary_10_1016_j_ajog_2018_01_040 crossref_primary_10_3390_biotech10030017 crossref_primary_10_1002_uog_20160 crossref_primary_10_1002_mgg3_545 crossref_primary_10_1002_uog_20284 crossref_primary_10_1016_j_tig_2012_10_013 crossref_primary_10_1002_pd_4092 crossref_primary_10_3109_14767058_2013_770464 crossref_primary_10_3390_ijms18020453 crossref_primary_10_1002_pd_4881 crossref_primary_10_1016_j_ajog_2014_03_042 crossref_primary_10_1002_ccr3_352 crossref_primary_10_1002_jcla_23035
Cites_doi	10.1093/nar/gng015 10.1097/00001703-200104000-00013 10.2307/2347973 10.1073/pnas.0810641105 10.1002/pd.2922 10.1016/j.ajog.2009.02.029 10.1056/NEJMoa043693 10.1373/clinchem.2011.165910 10.1371/journal.pone.0010439 10.1097/01.AOG.0000291570.63450.44 10.1016/j.ajog.2006.02.046 10.1002/pd.2637 10.1073/pnas.0808319105 10.1016/j.ajog.2010.09.028 10.1016/j.ajog.2004.12.093 10.1016/j.ajog.2008.07.063 10.1097/01.AOG.0000232512.46869.fc 10.1016/S0002-9378(98)70273-X 10.1136/bmj.c7401 10.1016/j.ajog.2006.07.033 10.1097/GIM.0b013e3182368a0e 10.1002/pd.2656 10.1016/j.ajog.2011.06.057 10.1371/journal.pone.0021791 10.1016/j.ajog.2004.03.090 10.1097/00006250-200701000-00054 10.1080/14767050600676851 10.1002/pd.2517 10.1016/S0002-9378(98)70274-1 10.1002/uog.128 10.1016/j.ajog.2010.12.060 10.1016/j.ajog.2004.06.098 10.1016/j.ajog.2009.03.002
ContentType	Journal Article
Copyright	2012 Mosby, Inc. Mosby, Inc. 2015 INIST-CNRS Copyright © 2012 Mosby, Inc. All rights reserved.
Copyright_xml	– notice: 2012 Mosby, Inc. – notice: Mosby, Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2012 Mosby, Inc. All rights reserved.
DBID	AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.ajog.2012.01.030
DatabaseName	CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1097-6868
EndPage	319.e9
ExternalDocumentID	22464072 25784870 10_1016_j_ajog_2012_01_030 S0002937812000610 1_s2_0_S0002937812000610
Genre	Journal Article
GroupedDBID	--- --K --M -ET .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1CY 1P~ 1~. 1~5 23M 2KS 354 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 6J9 7-5 85S 8F7 8P~ AAEDT AAEDW AAIKC AAIKJ AAKOC AALRI AAMNW AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYJJ AAYWO ABBQC ABCQX ABDPE ABFNM ABFRF ABJNI ABMAC ABMZM ABOCM ABPMR ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFCHL AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGNAY AGQPQ AGUBO AGYEJ AHDLI AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 C5W CAG COF CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IH2 IHE J1W K-O KOM LPU M41 MO0 N4W N9A NEJ NQ- O-L O9- OAUVE OBH OCB OGEVE OHH OHT OMK OQ. OVD P-8 P-9 P2P PC. PH~ Q38 R2- ROL RPZ RXW SDF SEL SES SEW SJN SPCBC SSH SSZ T5K TAE TEORI TWZ UDS UGJ UHB UHS UHU UKR UNMZH UV1 VH1 VVN WH7 WOQ WOW X6Y X7M XFW YFH YOC YYQ YZZ Z5R ZGI ZXP ZY1 ~G- ~H1 ~HD AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ RIG AAIAV ABLVK ABYKQ ADOJD AFDAS AHPSJ AJBFU G8K LCYCR ZA5 AAYXX CITATION XRW AGCQF AGRNS IQODW CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c491t-b1cf61c3bb8c2ac1e417be19d4d672a9ba9b43b8c80f0b9539582c8861fef66b3
ISICitedReferencesCount	233
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000302266000019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0002-9378 1097-6868
IngestDate	Sun Sep 28 06:53:26 EDT 2025 Thu Apr 03 06:55:10 EDT 2025 Mon Jul 21 09:12:48 EDT 2025 Tue Nov 18 22:17:49 EST 2025 Sat Nov 29 07:31:19 EST 2025 Fri Feb 23 02:34:13 EST 2024 Sun Feb 23 10:18:58 EST 2025 Tue Oct 14 19:31:30 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	4
Keywords	aneuploidy detection noninvasive prenatal diagnostics Down syndrome trisomy Chromosomal aberration Trisomy Gynecology Aneuploidy Obstetrics Blood Chromosome E18 Prenatal diagnosis Mother DNA Cell Edwards syndrome
Language	English
License	CC BY 4.0 Copyright © 2012 Mosby, Inc. All rights reserved.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c491t-b1cf61c3bb8c2ac1e417be19d4d672a9ba9b43b8c80f0b9539582c8861fef66b3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
PMID	22464072
PQID	963836911
PQPubID	23479
PageCount	3
ParticipantIDs	proquest_miscellaneous_963836911 pubmed_primary_22464072 pascalfrancis_primary_25784870 crossref_citationtrail_10_1016_j_ajog_2012_01_030 crossref_primary_10_1016_j_ajog_2012_01_030 elsevier_sciencedirect_doi_10_1016_j_ajog_2012_01_030 elsevier_clinicalkeyesjournals_1_s2_0_S0002937812000610 elsevier_clinicalkey_doi_10_1016_j_ajog_2012_01_030
PublicationCentury	2000
PublicationDate	2012-04-01
PublicationDateYYYYMMDD	2012-04-01
PublicationDate_xml	– month: 04 year: 2012 text: 2012-04-01 day: 01
PublicationDecade	2010
PublicationPlace	New York, NY
PublicationPlace_xml	– name: New York, NY – name: United States
PublicationTitle	American journal of obstetrics and gynecology
PublicationTitleAlternate	Am J Obstet Gynecol
PublicationYear	2012
Publisher	Mosby, Inc Elsevier
Publisher_xml	– name: Mosby, Inc – name: Elsevier
References	Fan, Blumenfeld, El-Sayed, Chueh, Quake (bib14) 2009; 200 Fan, Blumenfeld, Chitkara (bib17) 2008; 105 Ehrich, Deciu, Zwiefelhofer (bib20) 2011; 204 Tukey (bib26) 1977 Harper, Finning, Martin, Moise (bib12) 2004; 191 Rozenberg, Bussières, Chevret (bib6) 2006; 195 Chiu, Akolekar, Zheng (bib19) 2011; 342 Tynan, Angkachatchai, Ehrich, Paladino, van den Boom, Oeth (bib15) 2011; 204 Bianchi, Hanson (bib10) 2006; 19 Conover (bib28) 1971 Palomaki, Kloza, Lambert-Messerlian (bib22) 2011; 13 (bib8) 2007; 110 Chen, Chiu, Sun (bib18) 2011; 6 (bib1) 2007; 109 Sehnert, Rhees, Comstock (bib23) 2011; 57 Irizarry, Bolstad, Collin, Cope, Hobbs, Speed (bib27) 2003; 31 Shulman (bib21) 2011; 205 Nicolaides (bib31) 2003; 21 Alberry, Maddocks, Hadi (bib34) 2009; 200 Nicolaides (bib5) 2004; 191 Chiu, Chan, Gao (bib16) 2008; 105 Fan, Quake (bib24) 2010; 5 Cuckle (bib33) 2001; 13 Al-Mufti, Howard, Overton (bib11) 1998; 179 Bischoff, Lewis, Nguyen (bib9) 1998; 179 Caughey, Hopkins, Norton (bib7) 2006; 108 Sparks, Wang, Struble (bib25) 2012 Jan 6 Souka, Von Kaisenberg, Hyett, Sonek, Nicolaides (bib35) 2005; 192 Chu, Bunce, Hogge, Peters (bib30) 2010; 30 Royston (bib29) 1982; 31 Nicolaides (bib2) 2011; 31 Fang, Benn, Campbell, Bolnick, Prabulos, Egan (bib32) 2009; 201 Geifman-Holtzman, Grotegut, Gaughan (bib13) 2006; 195 Malone, Canick, Ball (bib3) 2005; 353 Wald (bib4) 2010; 30 Royston (10.1016/j.ajog.2012.01.030_bib29) 1982; 31 Souka (10.1016/j.ajog.2012.01.030_bib35) 2005; 192 Geifman-Holtzman (10.1016/j.ajog.2012.01.030_bib13) 2006; 195 Bianchi (10.1016/j.ajog.2012.01.030_bib10) 2006; 19 Chiu (10.1016/j.ajog.2012.01.030_bib19) 2011; 342 Fan (10.1016/j.ajog.2012.01.030_bib17) 2008; 105 Shulman (10.1016/j.ajog.2012.01.030_bib21) 2011; 205 Chiu (10.1016/j.ajog.2012.01.030_bib16) 2008; 105 Fan (10.1016/j.ajog.2012.01.030_bib24) 2010; 5 Al-Mufti (10.1016/j.ajog.2012.01.030_bib11) 1998; 179 Fang (10.1016/j.ajog.2012.01.030_bib32) 2009; 201 Sparks (10.1016/j.ajog.2012.01.030_bib25) 2012 Caughey (10.1016/j.ajog.2012.01.030_bib7) 2006; 108 Chu (10.1016/j.ajog.2012.01.030_bib30) 2010; 30 Rozenberg (10.1016/j.ajog.2012.01.030_bib6) 2006; 195 Alberry (10.1016/j.ajog.2012.01.030_bib34) 2009; 200 Harper (10.1016/j.ajog.2012.01.030_bib12) 2004; 191 Malone (10.1016/j.ajog.2012.01.030_bib3) 2005; 353 Irizarry (10.1016/j.ajog.2012.01.030_bib27) 2003; 31 Conover (10.1016/j.ajog.2012.01.030_bib28) 1971 Nicolaides (10.1016/j.ajog.2012.01.030_bib31) 2003; 21 (10.1016/j.ajog.2012.01.030_bib1) 2007; 109 Wald (10.1016/j.ajog.2012.01.030_bib4) 2010; 30 Fan (10.1016/j.ajog.2012.01.030_bib14) 2009; 200 Chen (10.1016/j.ajog.2012.01.030_bib18) 2011; 6 Tukey (10.1016/j.ajog.2012.01.030_bib26) 1977 Nicolaides (10.1016/j.ajog.2012.01.030_bib5) 2004; 191 Nicolaides (10.1016/j.ajog.2012.01.030_bib2) 2011; 31 Sehnert (10.1016/j.ajog.2012.01.030_bib23) 2011; 57 Tynan (10.1016/j.ajog.2012.01.030_bib15) 2011; 204 Cuckle (10.1016/j.ajog.2012.01.030_bib33) 2001; 13 Bischoff (10.1016/j.ajog.2012.01.030_bib9) 1998; 179 Ehrich (10.1016/j.ajog.2012.01.030_bib20) 2011; 204 Palomaki (10.1016/j.ajog.2012.01.030_bib22) 2011; 13 (10.1016/j.ajog.2012.01.030_bib8) 2007; 110 22464064 - Am J Obstet Gynecol. 2012 Apr;206(4):269-75
References_xml	– volume: 205 start-page: S9 year: 2011 end-page: S13 ident: bib21 article-title: One small step and one giant leap for noninvasive prenatal screening: an editorial publication-title: Am J Obstet Gynecol – volume: 19 start-page: 199 year: 2006 end-page: 207 ident: bib10 article-title: Sharpening the tools: a summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis publication-title: J Matern Fetal Neonatal Med – volume: 31 start-page: 7 year: 2011 end-page: 15 ident: bib2 article-title: Screening for fetal aneuploidies at 11 to 13 weeks publication-title: Prenat Diagn – volume: 204 start-page: 205.e1 year: 2011 end-page: 205.e11 ident: bib20 article-title: Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting publication-title: Am J Obstet Gynecol – volume: 13 start-page: 913 year: 2011 end-page: 920 ident: bib22 article-title: DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study publication-title: Genet Med – volume: 200 start-page: 543.e1 year: 2009 end-page: 543.e7 ident: bib14 article-title: Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy publication-title: Am J Obstet Gynecol – year: 1977 ident: bib26 article-title: Exploratory data analysis – volume: 108 start-page: 612 year: 2006 end-page: 616 ident: bib7 article-title: Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss publication-title: Obstet Gynecol – volume: 6 start-page: e21791 year: 2011 ident: bib18 article-title: Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing publication-title: PLoS One – volume: 204 start-page: 251.e1 year: 2011 end-page: 251.e6 ident: bib15 article-title: Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing publication-title: Am J Obstet Gynecol – volume: 31 start-page: e15 year: 2003 ident: bib27 article-title: Summaries of Affymetrix GeneChip probe level data publication-title: Nucleic Acids Res – volume: 201 start-page: 97.e1 year: 2009 end-page: 97.e5 ident: bib32 article-title: Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists publication-title: Am J Obstet Gynecol – volume: 200 start-page: 98.e1 year: 2009 end-page: 98.e6 ident: bib34 article-title: Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction publication-title: Am J Obstet Gynecol – volume: 109 start-page: 217 year: 2007 end-page: 227 ident: bib1 article-title: ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities publication-title: Obstet Gynecol – volume: 21 start-page: 313 year: 2003 end-page: 321 ident: bib31 article-title: Screening for chromosomal defects publication-title: Ultrasound Obstet Gynecol – volume: 179 start-page: 203 year: 1998 end-page: 209 ident: bib9 article-title: Prenatal diagnosis with use of fetal cells isolated from maternal blood: five-color fluorescent in situ hybridization analysis on flow-sorted cells for chromosomes X, Y, 13, 18, and 21 publication-title: Am J Obstet Gynecol – volume: 57 start-page: 1042 year: 2011 end-page: 1049 ident: bib23 article-title: Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood publication-title: Clin Chem – volume: 31 start-page: 115 year: 1982 end-page: 124 ident: bib29 article-title: An extension of Shapiro and Wilk's W test for normality to large samples publication-title: Appl Statistics – volume: 179 start-page: 210 year: 1998 end-page: 214 ident: bib11 article-title: Detection of fetal messenger ribonucleic acid in maternal blood to determine fetal RhD status as a strategy for noninvasive prenatal diagnosis publication-title: Am J Obstet Gynecol – volume: 13 start-page: 175 year: 2001 end-page: 181 ident: bib33 article-title: Integrating antenatal Down's syndrome screening publication-title: Curr Opin Obstet Gynecol – volume: 191 start-page: 1730 year: 2004 end-page: 1732 ident: bib12 article-title: Use of maternal plasma for noninvasive determination of fetal RhD status publication-title: Am J Obstet Gynecol – year: 2012 Jan 6 ident: bib25 article-title: Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy publication-title: Prenat Diagn – volume: 105 start-page: 266 year: 2008 end-page: 271 ident: bib17 article-title: Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood publication-title: Proc Natl Acad Sci U S A – volume: 192 start-page: 1005 year: 2005 end-page: 1021 ident: bib35 article-title: Increased nuchal translucency with normal karyotype publication-title: Am J Obstet Gynecol – start-page: 295 year: 1971 end-page: 301 ident: bib28 article-title: Practical nonparametric statistics – volume: 195 start-page: 1379 year: 2006 end-page: 1387 ident: bib6 article-title: Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population publication-title: Am J Obstet Gynecol – volume: 110 start-page: 1459 year: 2007 end-page: 1467 ident: bib8 article-title: ACOG practice bulletin no. 88: invasive prenatal testing for aneuploidy publication-title: Obstet Gynecol – volume: 342 start-page: c7401 year: 2011 ident: bib19 article-title: Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study publication-title: BMJ – volume: 353 start-page: 2001 year: 2005 end-page: 2011 ident: bib3 article-title: First- and second-trimester evaluation of risk (FASTER) research consortium publication-title: N Engl J Med – volume: 30 start-page: 1226 year: 2010 end-page: 1229 ident: bib30 article-title: A novel approach toward the challenge of accurately quantifying fetal DNA in maternal plasma publication-title: Prenat Diagn – volume: 105 start-page: 20458 year: 2008 end-page: 20463 ident: bib16 article-title: Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma publication-title: Proc Natl Acad Sci U S A – volume: 5 start-page: e10439 year: 2010 ident: bib24 article-title: Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics publication-title: PLoS One – volume: 30 start-page: 619 year: 2010 end-page: 621 ident: bib4 article-title: Prenatal screening for open neural tube defects and Down syndrome: three decades of progress publication-title: Prenat Diagn – volume: 195 start-page: 1163 year: 2006 end-page: 1173 ident: bib13 article-title: Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood–a meta analysis publication-title: Am J Obstet Gynecol – volume: 191 start-page: 45 year: 2004 end-page: 67 ident: bib5 article-title: Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities publication-title: Am J Obstet Gynecol – volume: 31 start-page: e15 year: 2003 ident: 10.1016/j.ajog.2012.01.030_bib27 article-title: Summaries of Affymetrix GeneChip probe level data publication-title: Nucleic Acids Res doi: 10.1093/nar/gng015 – volume: 13 start-page: 175 year: 2001 ident: 10.1016/j.ajog.2012.01.030_bib33 article-title: Integrating antenatal Down's syndrome screening publication-title: Curr Opin Obstet Gynecol doi: 10.1097/00001703-200104000-00013 – volume: 31 start-page: 115 year: 1982 ident: 10.1016/j.ajog.2012.01.030_bib29 article-title: An extension of Shapiro and Wilk's W test for normality to large samples publication-title: Appl Statistics doi: 10.2307/2347973 – volume: 105 start-page: 20458 year: 2008 ident: 10.1016/j.ajog.2012.01.030_bib16 article-title: Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0810641105 – year: 2012 ident: 10.1016/j.ajog.2012.01.030_bib25 article-title: Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy publication-title: Prenat Diagn doi: 10.1002/pd.2922 – volume: 201 start-page: 97.e1 year: 2009 ident: 10.1016/j.ajog.2012.01.030_bib32 article-title: Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2009.02.029 – volume: 353 start-page: 2001 year: 2005 ident: 10.1016/j.ajog.2012.01.030_bib3 article-title: First- and second-trimester evaluation of risk (FASTER) research consortium publication-title: N Engl J Med doi: 10.1056/NEJMoa043693 – volume: 57 start-page: 1042 year: 2011 ident: 10.1016/j.ajog.2012.01.030_bib23 article-title: Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood publication-title: Clin Chem doi: 10.1373/clinchem.2011.165910 – volume: 5 start-page: e10439 year: 2010 ident: 10.1016/j.ajog.2012.01.030_bib24 article-title: Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics publication-title: PLoS One doi: 10.1371/journal.pone.0010439 – volume: 110 start-page: 1459 year: 2007 ident: 10.1016/j.ajog.2012.01.030_bib8 article-title: ACOG practice bulletin no. 88: invasive prenatal testing for aneuploidy publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000291570.63450.44 – volume: 195 start-page: 1379 year: 2006 ident: 10.1016/j.ajog.2012.01.030_bib6 article-title: Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2006.02.046 – volume: 31 start-page: 7 year: 2011 ident: 10.1016/j.ajog.2012.01.030_bib2 article-title: Screening for fetal aneuploidies at 11 to 13 weeks publication-title: Prenat Diagn doi: 10.1002/pd.2637 – volume: 105 start-page: 266 year: 2008 ident: 10.1016/j.ajog.2012.01.030_bib17 article-title: Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0808319105 – volume: 204 start-page: 251.e1 year: 2011 ident: 10.1016/j.ajog.2012.01.030_bib15 article-title: Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2010.09.028 – volume: 192 start-page: 1005 year: 2005 ident: 10.1016/j.ajog.2012.01.030_bib35 article-title: Increased nuchal translucency with normal karyotype publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2004.12.093 – volume: 200 start-page: 98.e1 year: 2009 ident: 10.1016/j.ajog.2012.01.030_bib34 article-title: Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2008.07.063 – volume: 108 start-page: 612 year: 2006 ident: 10.1016/j.ajog.2012.01.030_bib7 article-title: Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000232512.46869.fc – volume: 179 start-page: 203 year: 1998 ident: 10.1016/j.ajog.2012.01.030_bib9 article-title: Prenatal diagnosis with use of fetal cells isolated from maternal blood: five-color fluorescent in situ hybridization analysis on flow-sorted cells for chromosomes X, Y, 13, 18, and 21 publication-title: Am J Obstet Gynecol doi: 10.1016/S0002-9378(98)70273-X – volume: 342 start-page: c7401 year: 2011 ident: 10.1016/j.ajog.2012.01.030_bib19 article-title: Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study publication-title: BMJ doi: 10.1136/bmj.c7401 – volume: 195 start-page: 1163 year: 2006 ident: 10.1016/j.ajog.2012.01.030_bib13 article-title: Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood–a meta analysis publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2006.07.033 – volume: 13 start-page: 913 year: 2011 ident: 10.1016/j.ajog.2012.01.030_bib22 article-title: DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study publication-title: Genet Med doi: 10.1097/GIM.0b013e3182368a0e – volume: 30 start-page: 1226 year: 2010 ident: 10.1016/j.ajog.2012.01.030_bib30 article-title: A novel approach toward the challenge of accurately quantifying fetal DNA in maternal plasma publication-title: Prenat Diagn doi: 10.1002/pd.2656 – volume: 205 start-page: S9 year: 2011 ident: 10.1016/j.ajog.2012.01.030_bib21 article-title: One small step and one giant leap for noninvasive prenatal screening: an editorial publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2011.06.057 – volume: 6 start-page: e21791 year: 2011 ident: 10.1016/j.ajog.2012.01.030_bib18 article-title: Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing publication-title: PLoS One doi: 10.1371/journal.pone.0021791 – volume: 191 start-page: 45 year: 2004 ident: 10.1016/j.ajog.2012.01.030_bib5 article-title: Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2004.03.090 – start-page: 295 year: 1971 ident: 10.1016/j.ajog.2012.01.030_bib28 article-title: Practical nonparametric statistics – volume: 109 start-page: 217 year: 2007 ident: 10.1016/j.ajog.2012.01.030_bib1 article-title: ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities publication-title: Obstet Gynecol doi: 10.1097/00006250-200701000-00054 – volume: 19 start-page: 199 year: 2006 ident: 10.1016/j.ajog.2012.01.030_bib10 article-title: Sharpening the tools: a summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis publication-title: J Matern Fetal Neonatal Med doi: 10.1080/14767050600676851 – year: 1977 ident: 10.1016/j.ajog.2012.01.030_bib26 – volume: 30 start-page: 619 year: 2010 ident: 10.1016/j.ajog.2012.01.030_bib4 article-title: Prenatal screening for open neural tube defects and Down syndrome: three decades of progress publication-title: Prenat Diagn doi: 10.1002/pd.2517 – volume: 179 start-page: 210 year: 1998 ident: 10.1016/j.ajog.2012.01.030_bib11 article-title: Detection of fetal messenger ribonucleic acid in maternal blood to determine fetal RhD status as a strategy for noninvasive prenatal diagnosis publication-title: Am J Obstet Gynecol doi: 10.1016/S0002-9378(98)70274-1 – volume: 21 start-page: 313 year: 2003 ident: 10.1016/j.ajog.2012.01.030_bib31 article-title: Screening for chromosomal defects publication-title: Ultrasound Obstet Gynecol doi: 10.1002/uog.128 – volume: 204 start-page: 205.e1 year: 2011 ident: 10.1016/j.ajog.2012.01.030_bib20 article-title: Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2010.12.060 – volume: 191 start-page: 1730 year: 2004 ident: 10.1016/j.ajog.2012.01.030_bib12 article-title: Use of maternal plasma for noninvasive determination of fetal RhD status publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2004.06.098 – volume: 200 start-page: 543.e1 year: 2009 ident: 10.1016/j.ajog.2012.01.030_bib14 article-title: Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2009.03.002 – reference: 22464064 - Am J Obstet Gynecol. 2012 Apr;206(4):269-75
SSID	ssj0002292
Score	2.5307968
Snippet	We sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18) using... Objective We sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18)...
SourceID	proquest pubmed pascalfrancis crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	319.e1
SubjectTerms	Adult aneuploidy detection Biological and medical sciences Case-Control Studies Chromosome aberrations Chromosomes, Human, Pair 18 - genetics DNA - blood DNA - genetics Down syndrome Down Syndrome - diagnosis Female Fetus Gynecology. Andrology. Obstetrics Humans Male Medical genetics Medical sciences noninvasive prenatal diagnostics Obstetrics and Gynecology Pregnancy Pregnancy Trimester, First - blood Prenatal Diagnosis - methods Risk Sensitivity and Specificity trisomy Trisomy - diagnosis
Title	Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0002937812000610 https://www.clinicalkey.es/playcontent/1-s2.0-S0002937812000610 https://dx.doi.org/10.1016/j.ajog.2012.01.030 https://www.ncbi.nlm.nih.gov/pubmed/22464072 https://www.proquest.com/docview/963836911
Volume	206
WOSCitedRecordID	wos000302266000019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1097-6868 dateEnd: 20160731 omitProxy: false ssIdentifier: ssj0002292 issn: 0002-9378 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEF6VFiEkhLgK4aj2gTfLlXe9Wdu8hVLE1QipReTNWq_XUUuxozit2h_BH-VXMHs5DrTlkJAiKz7GdjKfZ2fH38wg9FyAl0oli8Mq4mnIYqnCokxEyGNeCcKSkpcmUfhDMh6nk0n2cW3tu8-FOT1O6jo9O8tm_1XVsA2UrVNn_0Ld3UlhA3wHpcMS1A7LP1L8WAdYT4WhpeuClaY9SKkWyjUF14Fy0_xGHyB6NUl0DD-s5koFr8ajoCl00ADcUZOAAn6tKRZtie6mnU9XJtwyFXUvw6_nASWWk-lWndXzZW7966FevYqmAJzpNgG2WPT0vFZyJdS_PxPzL-2SfBm83O52LeYnheVD78zF4TQYdbs-uzi4tvPBwVLCMZDfuww4F-_QxBHWj3fsNa7k6ApP1Bh28LTsj1LWlkdZEvLUdu3xxp5GvIdq1jPdYIu2Fek5AmZDduEwYyMeR9viqJlqeiA1pV_dC6bV8t37-tb0nRGTFKWzATdoMszAAm-M3u5O3nV-A6UZ9ZM1LeBSvCwb8ecrXeZG3ZqJFh7uynZluXzaZNyngzvotpv34JHF6120pup76MaeY3bcR996sMUetriDLQZs4A622MMWNxXuYIsBttjDFmvYYg9bbGD7Ai9BiwG02KEUU2LO71dJ-gB9er17sPMmdK1CQskysggLIitOZFwUqaRCEsVIUiiSlazkCRVZAR8Ww840qqIiG8bZMKUyTTmpVMV5EW-i9bqp1SOEeVTCuJYI8JUTJuM4Y3JIUpj1DwVlcSQGiPh_Ppeujr5u53Kce8LkUa61lWtt5RHJQVsDFHQyM1tF5sqjY6_Q3OdHw4ieA_qulEouklKte6TbnOQtHJz_gsgBGnaSzu-2_vRvr7i1grbup2k3gIEjMEDYwy-HUUvjQdSqOWlzPezHHBytAXpoYbkUpkyTC-jjf7yrJ-jm0mw8RetgidQzdF2eLg7b-Ra6lkzSLffo_QCqNR0v
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Noninvasive+prenatal+detection+and+selective+analysis+of+cell-free+DNA+obtained+from+maternal+blood%3A+evaluation+for+trisomy+21+and+trisomy+18&rft.jtitle=American+journal+of+obstetrics+and+gynecology&rft.au=Sparks%2C+Andrew+B.&rft.au=Struble%2C+Craig+A.&rft.au=Wang%2C+Eric+T.&rft.au=Song%2C+Ken&rft.date=2012-04-01&rft.pub=Mosby%2C+Inc&rft.issn=0002-9378&rft.eissn=1097-6868&rft.volume=206&rft.issue=4&rft.spage=319.e1&rft.epage=319.e9&rft_id=info:doi/10.1016%2Fj.ajog.2012.01.030&rft.externalDocID=S0002937812000610
thumbnail_m	http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029378%2FS0002937811X00194%2Fcov150h.gif